<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Todorov-Volgyi K</submitter><funding>European Research Council</funding><pagination>325-336</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12880920</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>29(2)</volume><pubmed_abstract>Cerebral small vessel disease (SVD) is a common chronic cerebrovascular disorder with poorly understood pathomechanisms. Genetic studies have identified FOXF2 as a major risk gene for both SVD and stroke. FOXF2 encodes a transcription factor primarily expressed in brain pericytes and endothelial cells (ECs); however, its mechanistic role in cerebrovascular disease remains unknown. Here we show that Foxf2 maintains EC function through Tie2 signaling. RNA and chromatin sequencing identified FOXF2 as a transcriptional activator of Tie2 and other endothelial lineage-specific genes. The deletion of EC-specific Foxf2 in adult mice resulted in blood-brain barrier leakage, which worsened after experimental stroke. Proteomic analyses of Foxf2-deficient mouse brain-derived and human-induced pluripot</pubmed_abstract><journal>Nature neuroscience</journal><pubmed_title>The stroke risk gene Foxf2 maintains brain endothelial cell function via Tie2 signaling.</pubmed_title><pmcid>PMC12880920</pmcid><funding_grant_id>865323</funding_grant_id><pubmed_authors>Todorov MI</pubmed_authors><pubmed_authors>Gonzalez-Gallego J</pubmed_authors><pubmed_authors>Cernilogar FM</pubmed_authors><pubmed_authors>Cao J</pubmed_authors><pubmed_authors>Paquet D</pubmed_authors><pubmed_authors>Seker FB</pubmed_authors><pubmed_authors>Reyahi A</pubmed_authors><pubmed_authors>Schifferer M</pubmed_authors><pubmed_authors>Llovera G</pubmed_authors><pubmed_authors>Frerich S</pubmed_authors><pubmed_authors>Schillinger U</pubmed_authors><pubmed_authors>Malik R</pubmed_authors><pubmed_authors>Schroger L</pubmed_authors><pubmed_authors>Erturk A</pubmed_authors><pubmed_authors>Todorov-Volgyi K</pubmed_authors><pubmed_authors>Dichgans M</pubmed_authors><pubmed_authors>Plesnila N</pubmed_authors><pubmed_authors>Lichtenthaler SF</pubmed_authors><pubmed_authors>Carlsson P</pubmed_authors><pubmed_authors>Simons M</pubmed_authors><pubmed_authors>Muller SA</pubmed_authors><pubmed_authors>Roth S</pubmed_authors><pubmed_authors>Liesz A</pubmed_authors><pubmed_authors>Crusius D</pubmed_authors><pubmed_authors>Pedro LD</pubmed_authors><pubmed_authors>Schotta G</pubmed_authors></additional><is_claimable>false</is_claimable><name>The stroke risk gene Foxf2 maintains brain endothelial cell function via Tie2 signaling.</name><description>Cerebral small vessel disease (SVD) is a common chronic cerebrovascular disorder with poorly understood pathomechanisms. Genetic studies have identified FOXF2 as a major risk gene for both SVD and stroke. FOXF2 encodes a transcription factor primarily expressed in brain pericytes and endothelial cells (ECs); however, its mechanistic role in cerebrovascular disease remains unknown. Here we show that Foxf2 maintains EC function through Tie2 signaling. RNA and chromatin sequencing identified FOXF2 as a transcriptional activator of Tie2 and other endothelial lineage-specific genes. The deletion of EC-specific Foxf2 in adult mice resulted in blood-brain barrier leakage, which worsened after experimental stroke. Proteomic analyses of Foxf2-deficient mouse brain-derived and human-induced pluripot</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Feb</publication><modification>2026-07-15T06:32:12.899Z</modification><creation>2026-06-30T03:21:33.599Z</creation></dates><accession>S-EPMC12880920</accession><cross_references><pubmed>41398477</pubmed><doi>10.1038/s41593-025-02136-5</doi></cross_references></HashMap>